163 related articles for article (PubMed ID: 12799787)
1. [Fabry's disease: new therapeutic options for this lysosomal storage disorder].
Grau AJ; Schwaninger M; Goebel HH; Beck M
Nervenarzt; 2003 Jun; 74(6):489-96. PubMed ID: 12799787
[TBL] [Abstract][Full Text] [Related]
2. Genetics and Gene Therapy of Anderson-Fabry Disease.
Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
[TBL] [Abstract][Full Text] [Related]
3. Cerebral hemorrhage in Fabry's disease.
Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yasude T; Ushiyama M; Endo F; Fukushima Y; Ikeda S
J Hum Genet; 2010 Apr; 55(4):259-61. PubMed ID: 20300124
[TBL] [Abstract][Full Text] [Related]
4. [Fabry's disease; towards a treatment].
Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
[TBL] [Abstract][Full Text] [Related]
5. [Ocular findings in Fabry's disease].
Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease with special reference to neurological manifestations.
Banerjee TK
Eur Rev Med Pharmacol Sci; 2004; 8(6):275-81. PubMed ID: 15745387
[TBL] [Abstract][Full Text] [Related]
7. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
[TBL] [Abstract][Full Text] [Related]
8. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
Mahmud HM
J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
[TBL] [Abstract][Full Text] [Related]
9. [Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects].
Germain DP
J Soc Biol; 2002; 196(2):161-73. PubMed ID: 12360745
[TBL] [Abstract][Full Text] [Related]
10. [Fabry disease in light of recent review].
Uyama E
Brain Nerve; 2008 Nov; 60(11):1235-44. PubMed ID: 19069157
[TBL] [Abstract][Full Text] [Related]
11. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
Mignani R; Cagnoli L
J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
[TBL] [Abstract][Full Text] [Related]
13. [Heterozygous Fabry's disease. Case report with electron microscopic studies].
Luderschmidt C; Wolff HH
Hautarzt; 1980 Jul; 31(7):372-5. PubMed ID: 6249775
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease.
Tse KC; Chan KW; Tin VP; Yip PS; Tang S; Li FK; Ho YW; Lai KN; Chan TM
Nephrol Dial Transplant; 2003 Jan; 18(1):182-6. PubMed ID: 12480979
[TBL] [Abstract][Full Text] [Related]
15. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement therapy in patients with Fabry's disease.
Tsuboi K
J Int Med Res; 2007; 35(4):574-81. PubMed ID: 17697536
[TBL] [Abstract][Full Text] [Related]
17. [A case of Fabry's disease with chronic renal failure].
Suzuki T; Fujino T; Sugasawa M; Kohara Y; Toyama K; Sato T; Yasuda T; Sugiyama M; Maeba T; Owada S; Ishida M
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):448-53. PubMed ID: 10441995
[TBL] [Abstract][Full Text] [Related]
18. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
Germain DP
J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
[TBL] [Abstract][Full Text] [Related]
19. [Division-related function and organ-related therapy in Fabry's disease. An interdisciplinary challenge].
Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Baron R; Breunig F; Schaefer R; Strotmann J; Wanner C
Med Klin (Munich); 2009 Jan; 104(1):10-9. PubMed ID: 19142592
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.
Eng CM; Guffon N; Wilcox WR; Germain DP; Lee P; Waldek S; Caplan L; Linthorst GE; Desnick RJ;
N Engl J Med; 2001 Jul; 345(1):9-16. PubMed ID: 11439963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
